Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Churchyard, GavinCárdenas, Vicky
Chihota, Violet
Mngadi, Kathy
Sebe, Modulakgotla
Brumskine, William
Martinson, Neil
Yimer, Getnet
Wang, Shu-Hua
Garcia-Basteiro, Alberto L
Nguenha, Dinis
Masilela, LeeAnne
Waggie, Zainab
van den Hof, Susan
Charalambous, Salome
Cobelens, Frank
Chaisson, Richard E
Grant, Alison D
Fielding, Katherine L
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.Published in
Ann Intern Med 2021; 174(10):1367-76DOI
10.7326/M20-7577PMID
34424730ae974a485f413a2113503eed53cd6c53
10.7326/M20-7577
Scopus Count
Collections
Related articles
- Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda.
- Authors: Ferguson O, Jo Y, Pennington J, Johnson K, Chaisson RE, Churchyard G, Dowdy D
- Issue date: 2020 Oct
- Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
- Authors: Vernon A, Burman W, Benator D, Khan A, Bozeman L
- Issue date: 1999 May 29
- Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
- Authors: Belknap R, Holland D, Feng PJ, Millet JP, Caylà JA, Martinson NA, Wright A, Chen MP, Moro RN, Scott NA, Arevalo B, Miró JM, Villarino ME, Weiner M, Borisov AS, TB Trials Consortium iAdhere Study Team
- Issue date: 2017 Nov 21
- Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.
- Authors: Dooley KE, Savic R, Gupte A, Marzinke MA, Zhang N, Edward VA, Wolf L, Sebe M, Likoti M, Fyvie MJ, Shibambo I, Beattie T, Chaisson RE, Churchyard GJ, DOLPHIN Study Team
- Issue date: 2020 Jun
- Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
- Authors: Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, Moore RD, Chaisson RE
- Issue date: 2006 Apr 15